{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:29:50Z","timestamp":1787596190736,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinbiochem.2024.110842","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T20:35:48Z","timestamp":1731875748000},"page":"110842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The potential of anti-glutamic acid decarboxylase antibodies to support a diagnosis of autoimmune diabetes mellitus"],"prefix":"10.1016","volume":"135","author":[{"given":"Maryah","family":"Liepert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamayel","family":"Alhaqqan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Lochnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-9784","authenticated-orcid":false,"given":"Cathy J.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110842_b0005","series-title":"Diabetes Mellitus: A Fundamental and Clinical Text","author":"LeRoith","year":"2000"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.05.002","article-title":"The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes","volume":"44","author":"Boettler","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clinbiochem.2024.110842_b0015","article-title":"Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"issue":"Pt 10","key":"10.1016\/j.clinbiochem.2024.110842_b0020","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0025","doi-asserted-by":"crossref","first-page":"1111063","DOI":"10.3389\/fneur.2023.1111063","article-title":"Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1","volume":"14","author":"Zong","year":"2023","journal-title":"Front Neurol."},{"key":"10.1016\/j.clinbiochem.2024.110842_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3803\/EnM.2018.33.2.147","article-title":"Latent autoimmune diabetes in adults: current status and new horizons","volume":"33","author":"Pozzilli","year":"2018","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2024.110842_b0035","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/jc.2005-1623","article-title":"Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow","volume":"91","author":"Leslie","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110842_b0040","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dbi20-0001","article-title":"Subtypes of Type 2 diabetes determined from clinical parameters","volume":"69","author":"Ahlqvist","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7","volume":"36","author":"Hawa","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0050","doi-asserted-by":"crossref","DOI":"10.2337\/dc06-1696","article-title":"Non insulin requiring autoimmune diabetes study group, high titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes","volume":"30","author":"Buzzetti","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110842_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2337\/diab.42.2.359","article-title":"Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease","volume":"42","author":"Tuomi","year":"1993","journal-title":"Diabetes"},{"issue":"Pt 4","key":"10.1016\/j.clinbiochem.2024.110842_b0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1258\/000456307780945679","article-title":"Latent autoimmune diabetes in adults: Increased awareness will aid diagnosis","volume":"44","author":"Fielding","year":"2007","journal-title":"Ann. Clin. Biochem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110842_b0065","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2337\/diacare.18.12.1557","article-title":"GAD antibodies in NIDDM. ten-year follow-up from the diagnosis","volume":"18","author":"Niskanen","year":"1995","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110842_b0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1464-5491.2006.01915.x","article-title":"GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes","volume":"23","author":"Castleden","year":"2006","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110842_b0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13098-023-01069-y","article-title":"Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020","volume":"15","author":"Rodr\u00edguez Escobedo","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.clinbiochem.2024.110842_b0080","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0085","doi-asserted-by":"crossref","unstructured":"Diagnosis and Classification of Diabetes: standards of care in diabetes\u20142024. Diabetes Care 47 (2024) S20\u2013S42. doi:10.2337\/dc24-S002.","DOI":"10.2337\/dc24-S002"},{"key":"10.1016\/j.clinbiochem.2024.110842_b0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/dme.12700","article-title":"Latent autoimmune diabetes of the adult: current knowledge and uncertainty","volume":"32","author":"Laugesen","year":"2015","journal-title":"Diabet. Med."},{"key":"10.1016\/j.clinbiochem.2024.110842_b0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/ds15-0047","article-title":"Recognizing and appropriately treating latent autoimmune diabetes in adults","volume":"29","author":"O\u2019Neal","year":"2016","journal-title":"Diabet. Spectrum"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110842_b0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/diab.39.6.653","article-title":"Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes","volume":"39","author":"Christie","year":"1990","journal-title":"Diabetes"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202400136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202400136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:51:02Z","timestamp":1736866262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202400136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":20,"alternative-id":["S000991202400136X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110842","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of anti-glutamic acid decarboxylase antibodies to support a diagnosis of autoimmune diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110842"}}